SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-006733
Filing Date
2020-01-24
Accepted
2020-01-24 16:31:32
Documents
6
Period of Report
2020-01-21
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm205676d1_8k.htm 8-K 38337
2 EXHIBIT 3.1 tm205676d1_ex3-1.htm EX-3.1 9035
3 EXHIBIT 4.1 tm205676d1_ex4-1.htm EX-4.1 120351
4 GRAPHIC tm205676d1_ex31-1img001.jpg GRAPHIC 370426
5 GRAPHIC tm205676d1_ex31-1img002.jpg GRAPHIC 304258
6 GRAPHIC tm205676d1_ex31-1img003.jpg GRAPHIC 128174
  Complete submission text file 0001104659-20-006733.txt   1275490
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 20545888
SIC: 3841 Surgical & Medical Instruments & Apparatus